A citation-based method for searching scientific literature

Eric F Morand, Richard Furie, Yoshiya Tanaka, Ian N Bruce, Anca D Askanase, Christophe Richez, Sang-Cheol Bae, Philip Z Brohawn, Lilia Pineda, Anna Berglind, Raj Tummala. N Engl J Med 2020
Times Cited: 193







List of co-cited articles
982 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus.
Richard Furie, Munther Khamashta, Joan T Merrill, Victoria P Werth, Kenneth Kalunian, Philip Brohawn, Gabor G Illei, Jorn Drappa, Liangwei Wang, Stephen Yoo. Arthritis Rheumatol 2017
351
28

Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus.
Emily C Baechler, Franak M Batliwalla, George Karypis, Patrick M Gaffney, Ward A Ortmann, Karl J Espe, Katherine B Shark, William J Grande, Karis M Hughes, Vivek Kapur,[...]. Proc Natl Acad Sci U S A 2003
24

Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial.
Daniel J Wallace, Richard A Furie, Yoshiya Tanaka, Kenneth C Kalunian, Marta Mosca, Michelle A Petri, Thomas Dörner, Mario H Cardiel, Ian N Bruce, Elisa Gomez,[...]. Lancet 2018
169
22

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial.
Sandra V Navarra, Renato M Guzmán, Alberto E Gallacher, Stephen Hall, Roger A Levy, Renato E Jimenez, Edmund K-M Li, Mathew Thomas, Ho-Youn Kim, Manuel G León,[...]. Lancet 2011
985
21

Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study.
Munther Khamashta, Joan T Merrill, Victoria P Werth, Richard Furie, Kenneth Kalunian, Gabor G Illei, Jorn Drappa, Liangwei Wang, Warren Greth. Ann Rheum Dis 2016
262
21

Interferon and granulopoiesis signatures in systemic lupus erythematosus blood.
Lynda Bennett, A Karolina Palucka, Edsel Arce, Victoria Cantrell, Josef Borvak, Jacques Banchereau, Virginia Pascual. J Exp Med 2003
21

2019 update of the EULAR recommendations for the management of systemic lupus erythematosus.
Antonis Fanouriakis, Myrto Kostopoulou, Alessia Alunno, Martin Aringer, Ingeborg Bajema, John N Boletis, Ricard Cervera, Andrea Doria, Caroline Gordon, Marcello Govoni,[...]. Ann Rheum Dis 2019
363
20

Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial.
Joan T Merrill, C Michael Neuwelt, Daniel J Wallace, Joseph C Shanahan, Kevin M Latinis, James C Oates, Tammy O Utset, Caroline Gordon, David A Isenberg, Hsin-Ju Hsieh,[...]. Arthritis Rheum 2010
716
16

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus.
Richard Furie, Michelle Petri, Omid Zamani, Ricard Cervera, Daniel J Wallace, Dana Tegzová, Jorge Sanchez-Guerrero, Andreas Schwarting, Joan T Merrill, W Winn Chatham,[...]. Arthritis Rheum 2011
775
16

Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients.
Romain Banchereau, Seunghee Hong, Brandi Cantarel, Nicole Baldwin, Jeanine Baisch, Michelle Edens, Alma-Martina Cepika, Peter Acs, Jacob Turner, Esperanza Anguiano,[...]. Cell 2016
241
14

Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study.
Brad H Rovin, Richard Furie, Kevin Latinis, R John Looney, Fernando C Fervenza, Jorge Sanchez-Guerrero, Romeo Maciuca, David Zhang, Jay P Garg, Paul Brunetta,[...]. Arthritis Rheum 2012
678
14

Monoclonal antibody targeting BDCA2 ameliorates skin lesions in systemic lupus erythematosus.
Richard Furie, Victoria P Werth, Joseph F Merola, Lauren Stevenson, Taylor L Reynolds, Himanshu Naik, Wenting Wang, Romy Christmann, Agnes Gardet, Alex Pellerin,[...]. J Clin Invest 2019
78
17

Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis.
Richard Furie, Brad H Rovin, Frédéric Houssiau, Ana Malvar, Y K Onno Teng, Gabriel Contreras, Zahir Amoura, Xueqing Yu, Chi-Chiu Mok, Mittermayer B Santiago,[...]. N Engl J Med 2020
69
20


A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE).
Kenneth C Kalunian, Joan T Merrill, Romeo Maciuca, Jacqueline M McBride, Michael J Townsend, Xiaohui Wei, John C Davis, William P Kennedy. Ann Rheum Dis 2016
202
12

IFN-α kinoid in systemic lupus erythematosus: results from a phase IIb, randomised, placebo-controlled study.
Frederic A Houssiau, Aikaterini Thanou, Minodora Mazur, Edgar Ramiterre, Danny Alexis Gomez Mora, Maria Misterska-Skora, Risto Alfredo Perich-Campos, Svetlana A Smakotina, Sergio Cerpa Cruz, Bassem Louzir,[...]. Ann Rheum Dis 2020
23
52

New insights into the immunopathogenesis of systemic lupus erythematosus.
George C Tsokos, Mindy S Lo, Patricia Costa Reis, Kathleen E Sullivan. Nat Rev Rheumatol 2016
389
12

Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus.
Michelle Petri, Ana-Maria Orbai, Graciela S Alarcón, Caroline Gordon, Joan T Merrill, Paul R Fortin, Ian N Bruce, David Isenberg, Daniel J Wallace, Ola Nived,[...]. Arthritis Rheum 2012
12

Regulation of type I interferon responses.
Lionel B Ivashkiv, Laura T Donlin. Nat Rev Immunol 2014
12

Systemic lupus erythematosus.
George C Tsokos. N Engl J Med 2011
11

Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.
Kyriakos A Kirou, Christina Lee, Sandhya George, Kyriakos Louca, Margaret G E Peterson, Mary K Crow. Arthritis Rheum 2005
450
11

New therapies for systemic lupus erythematosus - past imperfect, future tense.
Grainne Murphy, David A Isenberg. Nat Rev Rheumatol 2019
49
20


Type I Interferons in Autoimmune Disease.
Mary K Crow, Mikhail Olferiev, Kyriakos A Kirou. Annu Rev Pathol 2019
68
14

Treat-to-target in systemic lupus erythematosus: recommendations from an international task force.
Ronald F van Vollenhoven, Marta Mosca, George Bertsias, David Isenberg, Annegret Kuhn, Kirsten Lerstrøm, Martin Aringer, Hendrika Bootsma, Dimitrios Boumpas, Ian N Bruce,[...]. Ann Rheum Dis 2014
305
9

Definition and initial validation of a Lupus Low Disease Activity State (LLDAS).
Kate Franklyn, Chak Sing Lau, Sandra V Navarra, Worawit Louthrenoo, Aisha Lateef, Laniyati Hamijoyo, C Singgih Wahono, Shun Le Chen, Ou Jin, Susan Morton,[...]. Ann Rheum Dis 2016
180
9

Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosus.
Jeffrey M Riggs, Richard N Hanna, Bhargavi Rajan, Kamelia Zerrouki, Jodi L Karnell, Divya Sagar, Inna Vainshtein, Erika Farmer, Kimberly Rosenthal, Chris Morehouse,[...]. Lupus Sci Med 2018
32
28

Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study.
Ronald F van Vollenhoven, Bevra H Hahn, George C Tsokos, Carrie L Wagner, Peter Lipsky, Zahi Touma, Victoria P Werth, Robert M Gordon, Bei Zhou, Benjamin Hsu,[...]. Lancet 2018
122
9

Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease.
Christian Lood, Luz P Blanco, Monica M Purmalek, Carmelo Carmona-Rivera, Suk S De Ravin, Carolyne K Smith, Harry L Malech, Jeffrey A Ledbetter, Keith B Elkon, Mariana J Kaplan. Nat Med 2016
557
9

Mapping systemic lupus erythematosus heterogeneity at the single-cell level.
Djamel Nehar-Belaid, Seunghee Hong, Radu Marches, Guo Chen, Mohan Bolisetty, Jeanine Baisch, Lynnette Walters, Marilynn Punaro, Robert J Rossi, Cheng-Han Chung,[...]. Nat Immunol 2020
25
36

Novel paradigms in systemic lupus erythematosus.
Thomas Dörner, Richard Furie. Lancet 2019
94
8

The 1982 revised criteria for the classification of systemic lupus erythematosus.
E M Tan, A S Cohen, J F Fries, A T Masi, D J McShane, N F Rothfield, J G Schaller, N Talal, R J Winchester. Arthritis Rheum 1982
8

2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis.
Antonis Fanouriakis, Myrto Kostopoulou, Kim Cheema, Hans-Joachim Anders, Martin Aringer, Ingeborg Bajema, John Boletis, Eleni Frangou, Frederic A Houssiau, Jane Hollis,[...]. Ann Rheum Dis 2020
79
10

High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus.
Vilija Oke, Iva Gunnarsson, Jessica Dorschner, Susanna Eketjäll, Agneta Zickert, Timothy B Niewold, Elisabet Svenungsson. Arthritis Res Ther 2019
33
24

Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus.
Gina S Garcia-Romo, Simone Caielli, Barbara Vega, John Connolly, Florence Allantaz, Zhaohui Xu, Marilynn Punaro, Jeanine Baisch, Cristiana Guiducci, Robert L Coffman,[...]. Sci Transl Med 2011
757
8

Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials.
Megan E B Clowse, Daniel J Wallace, Richard A Furie, Michelle A Petri, Marilyn C Pike, Piotr Leszczyński, C Michael Neuwelt, Kathryn Hobbs, Mauro Keiserman, Liliana Duca,[...]. Arthritis Rheumatol 2017
91
7

A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus.
Daniel J Wallace, William Stohl, Richard A Furie, Jeffrey R Lisse, James D McKay, Joan T Merrill, Michelle A Petri, Ellen M Ginzler, W Winn Chatham, W Joseph McCune,[...]. Arthritis Rheum 2009
352
7


American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis.
Bevra H Hahn, Maureen A McMahon, Alan Wilkinson, W Dean Wallace, David I Daikh, John D Fitzgerald, George A Karpouzas, Joan T Merrill, Daniel J Wallace, Jinoos Yazdany,[...]. Arthritis Care Res (Hoboken) 2012
715
7

Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort.
Ian N Bruce, Aidan G O'Keeffe, Vern Farewell, John G Hanly, Susan Manzi, Li Su, Dafna D Gladman, Sang-Cheol Bae, Jorge Sanchez-Guerrero, Juanita Romero-Diaz,[...]. Ann Rheum Dis 2015
215
7

Interferon target-gene expression and epigenomic signatures in health and disease.
Franck J Barrat, Mary K Crow, Lionel B Ivashkiv. Nat Immunol 2019
81
8

Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial.
Jing He, Ruijun Zhang, Miao Shao, Xiaozhen Zhao, Miao Miao, Jiali Chen, Jiajia Liu, Xiaoying Zhang, Xia Zhang, Yuebo Jin,[...]. Ann Rheum Dis 2020
56
12

Role of type I interferons in the activation of autoreactive B cells.
Kerstin Kiefer, Michael A Oropallo, Michael P Cancro, Ann Marshak-Rothstein. Immunol Cell Biol 2012
108
7

Tofacitinib Ameliorates Murine Lupus and Its Associated Vascular Dysfunction.
Yasuko Furumoto, Carolyne K Smith, Luz Blanco, Wenpu Zhao, Stephen R Brooks, Seth G Thacker, Zarzour Abdalrahman, Giuseppe Sciumè, Wanxia L Tsai, Anna M Trier,[...]. Arthritis Rheumatol 2017
106
7

Tubular cell and keratinocyte single-cell transcriptomics applied to lupus nephritis reveal type I IFN and fibrosis relevant pathways.
Evan Der, Hemant Suryawanshi, Pavel Morozov, Manjunath Kustagi, Beatrice Goilav, Saritha Ranabothu, Peter Izmirly, Robert Clancy, H Michael Belmont, Mordecai Koenigsberg,[...]. Nat Immunol 2019
109
7

Photosensitivity and type I IFN responses in cutaneous lupus are driven by epidermal-derived interferon kappa.
Mrinal K Sarkar, Grace A Hile, Lam C Tsoi, Xianying Xing, Jianhua Liu, Yun Liang, Celine C Berthier, William R Swindell, Matthew T Patrick, Shuai Shao,[...]. Ann Rheum Dis 2018
59
11

2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus.
Martin Aringer, Karen Costenbader, David Daikh, Ralph Brinks, Marta Mosca, Rosalind Ramsey-Goldman, Josef S Smolen, David Wofsy, Dimitrios T Boumpas, Diane L Kamen,[...]. Ann Rheum Dis 2019
193
7


The Dual Nature of Type I and Type II Interferons.
Amanda J Lee, Ali A Ashkar. Front Immunol 2018
135
7



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.